Tag: Tilray
Tilray, Inc. Reports 2020 Full Fiscal Year and Fourth Quarter Results
Revenue Increased 26% to $210.5 Million in 2020 Compared to Prior Year Net Loss $(3.0) Million in Q4 2020…
Tilray to Report 2020 Full Fiscal Year and Fourth Quarter Financial Results on February 17
Tilray Inc. (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced…
Tilray Announces Agreement with Grow Pharma to Import and Distribute Medical Cannabis Products in the United Kingdom
Tilray Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced…
Tilray Exports First Shipment of Medical Cannabis to Spain
Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced…
Tilray Receives the First and Only Market Authorization to Offer Medical Cannabis Products in Portugal
Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced…
Reason #3 to invest in American cannabis MSOs over Canadian LPs: Responsible shareholder dilution
This article is the third in a 10 part series on why you should invest…
Reason 1 to invest in American cannabis MSOs over Canadian LPs: Gross profits
This article is the first in a 10 part series on why you should invest…
Recent Comments